摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二甲基吡咯-3,5-二羧酸 | 5434-29-7

中文名称
2,4-二甲基吡咯-3,5-二羧酸
中文别名
3,5-二甲基-1H-吡咯-2,4-二羧酸;3,5-二甲基-2,4-吡咯二羧酸
英文名称
NSC 15758
英文别名
3,5-dimethyl-pyrrole-2,4-dicarboxylic acid;3,5-Dimethyl-pyrrol-2,4-dicarbonsaeure;3,5-dimethyl-1H-pyrrole-2,4-dicarboxylic acid
2,4-二甲基吡咯-3,5-二羧酸化学式
CAS
5434-29-7
化学式
C8H9NO4
mdl
MFCD00826671
分子量
183.164
InChiKey
LGAFIBCWNKPENX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    260 °C (decomp)
  • 沸点:
    456.8±45.0 °C(Predicted)
  • 密度:
    1.461±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    90.4
  • 氢给体数:
    3
  • 氢受体数:
    4

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933990090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302,H317

SDS

SDS:19a696f4ff7a59dcbf34a2c8746a8770
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,4-二甲基吡咯-3,5-二羧酸 为溶剂, 反应 8.0h, 以29 g的产率得到2,4-二甲基吡咯
    参考文献:
    名称:
    An Improved Two-step Preparation of 2,4-Dimethylpyrrole
    摘要:
    DOI:
    10.1080/00304948.2011.582005
  • 作为产物:
    描述:
    2,4-二甲基吡咯-3,5-二羧酸二乙酯 在 potassium hydroxide 作用下, 以 为溶剂, 反应 1.0h, 生成 2,4-二甲基吡咯-3,5-二羧酸
    参考文献:
    名称:
    An Improved Two-step Preparation of 2,4-Dimethylpyrrole
    摘要:
    DOI:
    10.1080/00304948.2011.582005
点击查看最新优质反应信息

文献信息

  • 1H-pyrrole-2,4-dicarbonyl-derivatives and their use as flavoring agents
    申请人:IMAX Discovery GmbH
    公开号:EP2832233A1
    公开(公告)日:2015-02-04
    The present invention primarily relates to 1H-pyrrole-2,4-dicarbonyl-derivatives of Formula (I) wherein R1, R2, R3, Z. Z' and J are as defined in the description, to mixtures thereof and to the use thereof as flavoring agents. The compounds in accordance with the present invention are suitable for producing, imparting, or intensifying an umami flavor. The invention further relates to flavoring mixtures, compositions for oral consumption as well as ready-to-eat, ready-to-use and semifinished products, comprising an effective amount of the compound of Formula (I) or of a mixture of compounds of Formula (I) and to specific methods for producing, imparting, modifying and/or intensifying specific flavor impressions.
    本发明主要涉及式(I)的1H-吡咯-2,4-二羰基衍生物,其中R1、R2、R3、Z、Z'和J按描述定义,及其混合物,以及用作调味剂的使用。根据本发明的化合物适用于生产、赋予或增强鲜味。本发明进一步涉及包含式(I)化合物或式(I)化合物混合物的有效量的调味混合物、口腔消费的组成物以及即食、即用和半成品,以及用于生产、赋予、改变和/或增强特定风味印象的特定方法。
  • Indolinone derivatives
    申请人:——
    公开号:US20040198804A1
    公开(公告)日:2004-10-07
    Compounds of formula (I) 1 in which R 1 , R 2 , R 3 and R 4 have the meanings given in the specification, are receptor tyrosine kinase inhibitors useful in the treatment of proliferative disorders, such as cancer.
    式(I)1的化合物中,其中R1、R2、R3和R4具有规范中给出的含义,是用于治疗增殖性疾病,例如癌症的受体酪氨酸激酶抑制剂。
  • 8-ARM POLYETHYLENE GLYCOL DERIVATIVE, MANUFACTURING METHOD AND MODIFIED BIO-RELATED SUBSTANCE THEREBY
    申请人:Xiamen Sinopeg Biotech Co., Ltd.
    公开号:EP3315531A1
    公开(公告)日:2018-05-02
    Disclosed are an 8-arm polyethylene glycol (PEG) derivative (formula 1), manufacturing method and modified bio-related substance thereby, wherein a tetravalent group U and four trivalent groups Ec form a highly symmetric octavalent central structure CORE0 together, Lc connects the octavalent center to eight PEG arms having polydiversity or monodiversity and having n1-n8 as the degrees of polymerization thereof. The terminal of one PEG chain is connected to at least one functional group F (k ≥ 1), and said PEG chain and F can be directly connected (g = 0) or connected with a divalent linking group L0 connected with a terminal branched group G (g = 1) therebetween. The latter provides more reacting sites to combine more pharmaceutical molecules, thereby increasing the drug loading capacity. The near-center symmetric structure of the derivative allows more precise control over the molecular weight during large-scale production, thereby facilitating acquisition of a product having a narrower molecular weight distribution. A bio-related substance modified thereby has a more uniform and controllable performance.
    本发明公开了一种 8 臂聚乙二醇(PEG)衍生物(式 1)、其制造方法和改性生物相关物质,其中一个四价基团 U 和四个三价基团 Ec 共同形成一个高度对称的八价中心结构 CORE0,Lc 将八价中心连接到八个 PEG 臂上,这些 PEG 臂具有多元性或单元性,其聚合度为 n1-n8。一条 PEG 链的末端与至少一个官能团 F(k ≥ 1)相连,所述 PEG 链和 F 可以直接相连(g = 0),也可以通过二价连接基 L0 与中间的末端支化基 G(g = 1)相连。后者提供了更多的反应位点,可以结合更多的药物分子,从而提高药物负载能力。衍生物的近中心对称结构可以在大规模生产过程中更精确地控制分子量,从而有利于获得分子量分布更窄的产品。由此改性的生物相关物质具有更均匀、更可控的性能。
  • Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof
    申请人:Xiamen Sinopeg Biotech Co., Ltd.
    公开号:US10660969B2
    公开(公告)日:2020-05-26
    Disclosed are an 8-arm polyethylene glycol (PEG) derivative (formula 1), manufacturing method and modified bio-related substance thereby, wherein a tetravalent group U and four trivalent groups Ec form a highly symmetric octavalent central structure CORE0 together, Lc connects the octavalent center to eight PEG arms having polydiversity or monodiversity and having n1-n8 as the degrees of polymerization thereof. The terminal of one PEG chain is connected to at least one functional group F (k≥1), and said PEG chain and F can be directly connected (g=0) or connected with a divalent linking group L0 connected with a terminal branched group G (g=1) therebetween. The latter provides more reacting sites to combine more pharmaceutical molecules, thereby increasing the drug loading capacity. The near-center symmetric structure of the derivative allows more precise control over the molecular weight during large-scale production, thereby facilitating acquisition of a product having a narrower molecular weight distribution. A bio-related substance modified thereby has a more uniform and controllable performance.
    本发明公开了一种 8 臂聚乙二醇(PEG)衍生物(式 1)、其制造方法和改性生物相关物质,其中一个四价基团 U 和四个三价基团 Ec 共同形成一个高度对称的八价中心结构 CORE0,Lc 将八价中心连接到八个 PEG 臂上,这些 PEG 臂具有多元性或单元性,其聚合度为 n1-n8。一条 PEG 链的末端与至少一个官能团 F(k≥1)相连,所述 PEG 链和 F 可以直接相连(g=0),也可以通过二价连接基 L0 与末端支化基 G(g=1)相连。后者提供了更多的反应位点,可结合更多的药物分子,从而提高药物负载能力。衍生物的近中心对称结构可以在大规模生产过程中更精确地控制分子量,从而有利于获得分子量分布更窄的产品。由此改性的生物相关物质具有更均匀、更可控的性能。
  • Multifunctionalized polyethylene glycol derivative and preparation method therefor
    申请人:XIAMEN SINOPEG BIOTECH CO., LTD.
    公开号:US11324827B2
    公开(公告)日:2022-05-10
    Disclosed are a multifunctionalized polyethylene glycol derivative and a preparation method therefor. The derivative has an H-shaped structure as represented by formula (1) and comprises one linear core LPEG and four PEG branch chains, where n1, n2, n3, and n4 respectively are the degrees of polymerization of the branch chains, U1 and U2 are trivalent branching groups connecting the core LPEG to two of the PEG branch chains, F1 and F2 contain a functional group or a protected form R01 thereof and may or may not contain a branched group G, correspondingly, the number of R01 is one or more, F1 and F2 are either identical or different, any one linking group in the molecule or any linking group formed with an adjacent heteroatom group can either remain stable or be degraded, and any one PEG segment in the molecule is discretely polydispersed or monodispersed. The multifunctional polyethylene glycol is flexible and diverse in terms of branch structures and the lengths of branching arms, has various parameters and performance indicators that are adjustable and easy to control, and has a broad applicability.
    本发明公开了一种多功能聚乙二醇衍生物及其制备方法。该衍生物具有由式(1)表示的 H 型结构,包括一个线性核心 LPEG 和四个 PEG 支链,其中 n1、n2、n3 和 n4 分别为支链的聚合度,U1 和 U2 为连接核心 LPEG 和两个 PEG 支链的三价支化基团、F1 和 F2 含有一个官能团或其保护形式 R01,可以含有或不含有支链基团 G,相应地,R01 的数目为一个或多个,F1 和 F2 要么相同要么不同,分子中的任何一个连接基团或与相邻杂原子基团形成的任何连接基团要么保持稳定,要么降解,分子中的任何一个 PEG 段离散多分散或单分散。多功能聚乙二醇的支链结构和支臂长度灵活多样,各种参数和性能指标可调且易于控制,具有广泛的适用性。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台